Absent T Lymphocytes

Search Trials
Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma
Status:
Active, not recruiting
Last Changed:
Jun 18, 2021
First Changed:
Sep 28, 2015
Disease(s):
Anaplastic Large Cell Lymphoma, ALK-Negative
Intervention(s):
Autologous Hematopoietic Stem Cell TransplantationCyclophosphamideDoxorubicin HydrochlorideEtoposideLaboratory Biomarker AnalysisLenalidomidePeripheral Blood Stem Cell TransplantationPrednisoneVincristine Sulfate
Rare Disease Patient Registry & Natural History Study – Coordination of Rare Diseases at Sanford
Status:
Recruiting
Last Changed:
Jun 27, 2022
First Changed:
Feb 15, 2013
Disease(s):
Rare Disorders
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
Status:
Recruiting
Last Changed:
May 5, 2021
First Changed:
Feb 21, 2019
Disease(s):
Melanoma
Intervention(s):
XmAb®22841Pembrolizumab (Keytruda®)
Safety and Immunogenicity of Candidate HIV Vaccines Given Sequentially
Status:
Active, not recruiting
Last Changed:
Mar 29, 2022
First Changed:
Sep 24, 2020
Disease(s):
Healthy
Intervention(s):
ChAdOx1.HTI and MVA.HTI
Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection
Status:
Recruiting
Last Changed:
Nov 19, 2021
First Changed:
Jun 22, 2021
Disease(s):
Kidney Transplantation
Intervention(s):
Cytotect

Connect. Empower. Inspire.